Finanzen von PomDoctor Ltd (POM)POMPomDoctor Ltd

Evaluating the bottom line, PomDoctor Ltd maintains a gross margin of 13.07%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -29.14%, while the net margin is -32.74%. These profitability ratios, combined with a Return on Equity (ROE) of N/A, provide a clear picture of how effectively POM converts its operational activities into shareholder value.

In the context of the broader market, POM competes directly with industry leaders such as JWEL and RDGT. With a market capitalization of $7.31M, it holds a significant position in the sector. When comparing efficiency, POM's gross margin of 13.07% stands against JWEL's 8.16% and RDGT's 3.92%. Such benchmarking helps identify whether PomDoctor Ltd is trading at a premium or discount relative to its financial performance.

PomDoctor reported a revenue increase of 16.7% for FY 2025, reaching approximately USD 57.2 million, but the gross margin decreased to 13.1% from 13.9% in FY 2024, indicating challenges in maintaining profitability.